Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Active Non-infectious Uveitis (VISUAL I)
NCT01138657Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2010
- Primary completion
- Jul 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in non-infectious intermediate uveitis, Posterior uveitis (non-infectious), non-infectious panuveitis (NIU), sponsored by AbbVie Inc.. Started Aug 2010; status: completed.
02
Drugs
03
Conditions
non-infectious intermediate uveitisPosterior uveitis (non-infectious)non-infectious panuveitis (NIU)
Beyond the preview
Go deeper on NCT01138657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138657.